Clovis Oncology, Inc. Skyrocketed
Fri, Jul 01, 2022 at 07:35 PM
Clovis Oncology, Inc. (CLVS:NASDAQ) jumped higher at $2.85, representing a gain of 58.3%. On Fri, Jul 01, 2022, CLVS:NASDAQ touched a New 2-Week High of $2.85. The stock got featured on our News Catalysts scanner on Thu, Jun 16, 2022 at 07:32 PM in the 'BIOTECH' category. From Fri, Jun 17, 2022, the stock recorded 55.56% Up Days and 80.00% Green Days
About Clovis Oncology, Inc. (CLVS:NASDAQ)
Clovis Oncology Inc is a biopharmaceutical company focused on acquiring, developing and commercializing cancer treatments in the United States, Europe and other international markets.
Top 10 Gainers:
- Omeros Corporation (OMER:NASDAQ), 68.73%
- Clovis Oncology, Inc. (CLVS:NASDAQ), 58.33%
- Agrico Acquisition Corp. (RICO:NASDAQ), 43.66%
- Fast Radius Inc. (FSRD:NASDAQ), 41.15%
- Faraday Future Intelligent Electric Inc. (FFIE:NASDAQ), 36.54%
- Quoin Pharmaceuticals Ltd. (QNRX:NASDAQ), 36.15%
- Inter & Co. Inc. (INTR:NASDAQ), 31.9%
- Shift Technologies Inc. (SFT:NASDAQ), 28.9%
- Accolade Inc. (ACCD:NASDAQ), 28.78%
- Mega Matrix Corp Com (MTMT:NYSEMKT), 25.74%